 It was used both on its own and, in combination with phentermine, as part of the anti-obesity medication Fen-Phen.In June 2020, fenfluramine was approved for medical use in the United States with an indication to treat Dravet syndrome.The effectiveness of fenfluramine for the treatment of seizures associated with Dravet syndrome was demonstrated in two clinical studies in 202 subjects between ages two and eighteen.